US equities |
MU $983.23 ▲+5.86% META $612.49 ▼-1.24% GOOGL $324.89 ▲+1.34% NVDA $215.38 ▼-1.17% MSFT $531.01 ▼-0.06% TSLA $404.22 ▼-0.80% SPCX $145.23 ▼-2.25% SNDK $1,404.77 ▲+7.66%
FinancialContent

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.8900 +0.0100 (+1.14%)
Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Fractyl Health&#39;s Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs ↗
Fractyl Health (NASDAQ: GUTS) released positive 6-month results from its REVEAL-1 study in obese patients who discontinued GLP-1 therapy. 
Via Benzinga
News headline image
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl (GUTS) Q3 2025 Earnings Call Transcript ↗
Fractyl (GUTS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
GUTS Stock Rallied About 28% Today – Here’s Why ↗
Via Stocktwits
News headline image
An Overview of Fractyl Health's Earnings ↗
 
Via Benzinga
News headline image
Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Preview: Fractyl Health's Earnings ↗
 
Via Benzinga
News headline image
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
MAGA Stocks Undercard: SNYR GUTS MRM MYSE Under $3 To Watch Now….more inside
Via AB Newswire
Topics Economy
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million. 
Via Benzinga
News headline image
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors 
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
 
Via Benzinga
News headline image
Fractyl Health Posts 62% Wider Q2 Loss ↗
Via The Motley Fool
News headline image
FRACTYL HEALTH INC (NASDAQ:GUTS) Reports Wider-Than-Expected Q2 2025 Loss Amid Clinical Progress ↗
Fractyl Health reports Q2 2025 net loss of $27.9M, missing EPS estimates. No revenue, but clinical progress in Revita and Rejuva programs. Stock dips amid investor concerns. 
Via Chartmill
News headline image
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
What's going on in today's session ↗
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Nasdaq Surges 1%; Uber Sales Top Estimates ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >